Adam Morgan insider trades
Open-market stock purchases and sales by Adam Morgan, Director at Heron Therapeutics, Inc /de/, from SEC Form 4 filings since Feb 22, 2023.
Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -77%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |